Concepedia

Linolenic Acid-Metronidazole: a Compound Relieving Drug Resistance and Inhibiting Helicobacter pylori

Yuanyuan Dai, Chun Qin, Gan-Rong Huang, Yan-Chun Qin, Yong-Yi Huang, Yong-Yi Huang, Yan-Qiang Huang, Yan-Qiang Huang, Lijuan Zhao

Antimicrobial Agents and Chemotherapy · 2022 · 11 citations · 18 references

DOIFull text

Open access

Concepts

Abstract

Metronidazole (Met) is the first choice for treating Helicobacter pylori ( Hp ). However, Hp is easy to resistant, making Met unable to be widely used.

References

18

Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosis

Evelina Tacconelli, Elena Carrara, Alessia Savoldi et al. · The Lancet Infectious Diseases · 2017 · 6.1K citations · Full text

, , +14

Management of <i>Helicobacter pylori</i> infection—the Maastricht V/Florence Consensus Report

Peter Malfertheiner, Françis Mégraud, Colm O’Morain et al. · Gut · 2016 · 2.9K citations · Full text

, , +13

<i>Helicobacter pylori</i> resistance to antibiotics in Europe and its relationship to antibiotic consumption

Françis Mégraud, Samuel Coenen, Ann Versporten et al. · Gut · 2012 · 832 citations

, , +14

Fatty Acids and Derivatives as Antimicrobial Agents

Jon J. Kabara, Dennis M. Swieczkowski, Anthony J. Conley et al. · Antimicrobial Agents and Chemotherapy · 1972 · 776 citations · Full text

, , +13

Gastric microbes associated with gastric inflammation, atrophy and intestinal metaplasia 1 year after <i>Helicobacter pylori</i> eradication

Joseph J.�Y. Sung, Olabisi Oluwabukola Coker, Eagle SH Chu et al. · Gut · 2020 · 261 citations · Full text

, , +15